American Century Companies
ATRS

American Century Companies’s Antares Pharma, Inc. ATRS Stock Holding History

American Century Companies’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-112,203
Closed -$408K – 2403
2021
Q3 		$408K Buy
+112,203
New +$454K ﹤0.01% 1961

Other funds holding ATRS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

American Century Companies's ATRS Position: Q4 2021 in Review

American Century Companies sold out of Antares Pharma, Inc. (ATRS) in Q4 2021, closing a stake of 112,203 shares — an estimated $408K sold.

American Century Companies first reported a position in ATRS in Q3 2021 and held it in 1 quarter. The position peaked at $408K in Q3 2021. 162 funds tracked by Wall St. Rank hold ATRS as of Q4 2021.

  • American Century Companies reported no remaining Antares Pharma, Inc. position as of Q4 2021 after selling out during the quarter.
  • American Century Companies sold 112,203 Antares Pharma, Inc. shares in Q4 2021, an estimated $408K.
  • American Century Companies first reported a position in Antares Pharma, Inc. in Q3 2021 and held it in 1 quarter.
  • American Century Companies's Antares Pharma, Inc. position peaked at $408K in Q3 2021.
  • 162 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2021.

Based on American Century Companies's 13F filing for Q4 2021, filed 7 Feb 2022.